Russell Investments Group, Ltd. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$31,000
-56.3%
61,157
-37.0%
0.00%
Q2 2020$71,000
+36.5%
97,138
+83.3%
0.00%
Q1 2020$52,000
-92.6%
53,001
-84.4%
0.00%
-100.0%
Q4 2019$703,000
-45.8%
340,708
-23.3%
0.00%
-66.7%
Q3 2019$1,297,000
-31.2%
444,263
+78.3%
0.00%
-25.0%
Q2 2019$1,886,000
-29.9%
249,203
+22.6%
0.00%
-20.0%
Q1 2019$2,691,000
+65.7%
203,268
+92.6%
0.01%
+25.0%
Q4 2018$1,624,000
+60.8%
105,523
+105.3%
0.00%
+100.0%
Q3 2018$1,010,000
-11.8%
51,389
+28.8%
0.00%0.0%
Q2 2018$1,145,000
+10.3%
39,891
-9.1%
0.00%0.0%
Q1 2018$1,038,000
+4.8%
43,8910.0%0.00%0.0%
Q4 2017$990,000
-7.0%
43,891
-2.4%
0.00%0.0%
Q3 2017$1,064,000
+5.8%
44,991
-11.9%
0.00%0.0%
Q2 2017$1,006,000
-13.1%
51,091
-7.3%
0.00%0.0%
Q1 2017$1,157,000
+5.7%
55,104
-7.7%
0.00%0.0%
Q4 2016$1,095,00059,6910.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders